164 tracked 13F filers disclose a position in URGN as of the latest SEC 13F filings, a combined $1.1B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | $167.2M | 4.5M | —Held | Q2 2026 | |
| 2 | BlackRock, Inc. | $51.2M | 2.8M | ▲+9.4% Added · +245K sh | Q1 2026 | |
| 3 | TORONTO DOMINION BANK | $47.0M | 2.6M | ▲New +2.6M sh | Q1 2026 | |
| 4 | MORGAN STANLEY | $46.0M | 2.6M | ▼−0.1% Reduced · −3K sh | Q1 2026 | |
| 5 | Kynam Capital Management, LP | $40.4M | 2.2M | ▲New +2.2M sh | Q1 2026 | |
| 6 | Jefferies Financial Group Inc. | $39.5M | 2.2M | —Held | Q1 2026 | |
| 7 | Paradigm Biocapital Advisors LP | $30.6M | 1.7M | ▼−62% Reduced · −2.8M sh | Q1 2026 | |
| 8 | ACORN CAPITAL ADVISORS, LLC | $61.6M | 1.7M | —Held | Q2 2026 | |
| 9 | AMERICAN CENTURY COMPANIES INC | $29.4M | 1.6M | ▲+21% Added · +279K sh | Q1 2026 | |
| 10 | FRONTIER CAPITAL MANAGEMENT CO LLC | $55.5M | 1.5M | ▲+15% Added · +194K sh | Q2 2026 | |
| 11 | Opaleye Management Inc. | $25.7M | 1.4M | ▲+433% Added · +1.2M sh | Q1 2026 | |
| 12 | SILVERARC CAPITAL MANAGEMENT, LLC | $47.9M | 1.3M | ▼−13% Reduced · −201K sh | Q2 2026 | |
| 13 | MENORA MIVTACHIM HOLDINGS LTD. | $42.4M | 1.2M | —Held | Q2 2026 | |
| 14 | D. E. Shaw & Co., Inc. | $18.4M | 1.0M | ▲+6.3% Added · +61K sh | Q1 2026 | |
| 15 | STATE STREET CORP | $36.9M | 1.0M | ▲+15% Added · +129K sh | Q2 2026 | |
| 16 | MPM BioImpact LLC | $17.0M | 944K | ▲+0.3% Added · +2K sh | Q1 2026 | |
| 17 | J. Goldman & Co LP | $16.9M | 939K | ▲+83% Added · +426K sh | Q1 2026 | |
| 18 | ORBIMED ADVISORS LLC | $15.7M | 875K | —Held | Q1 2026 | |
| 19 | Soleus Capital Management, L.P. | $30.5M | 830K | ▲+14% Added · +103K sh | Q2 2026 | |
| 20 | Migdal Insurance & Financial Holdings Ltd. | $28.4M | 771K | —Held | Q2 2026 | |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | $22.5M | 610K | ▲+17% Added · +87K sh | Q2 2026 | |
| 22 | GOLDMAN SACHS GROUP INC | $10.8M | 599K | ▲+30% Added · +139K sh | Q1 2026 | |
| 23 | Woodline Partners LP | $9.0M | 501K | —Held | Q1 2026 | |
| 24 | Boxer Capital Management, LLC | $9.0M | 500K | —Held | Q1 2026 | |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | $7.4M | 410K | →First observed position No prior filed position | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 10 funds opened a new position in URGN and 15 added to an existing one, while 21 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 67 funds | $47.5B |
| MICROSOFT CORPMSFT | 66 funds | $158.2B |
| AMAZON.COM INCAMZN | 66 funds | $110.6B |
| BROADCOM INCAVGO | 65 funds | $95.5B |
| NVIDIA CORPNVDA | 64 funds | $235.9B |
| META PLATFORMS INC-CLASS AMETA | 64 funds | $66.8B |
| INTUITIVE SURGICAL INCISRG | 64 funds | $17.1B |
| MICRON TECHNOLOGY INCMU | 62 funds | $20.7B |
| APPLE INCAAPL | 61 funds | $173.2B |
| ALPHABET INC-CL CGOOG | 61 funds | $78.9B |
| TESLA INCTSLA | 61 funds | $43.0B |
| VISA INC-CLASS A SHARESV | 61 funds | $34.9B |
Ranked by how many of URGN's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 10K | $400K |
| Jun 22, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 10K | $350K |
| Jun 8, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 5K | $143K |
| May 8, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 10K | $300K |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 2K | $36K |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 4K | $73K |
| Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 2K | $36K |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | Sell (S) | 3K | $63K |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | Sell (S) | 2K | $32K |
| Feb 3, 2026 | Smith Jason Drew | General Counsel | Sell (S) | 3K | $52K |
| Nov 19, 2025 | Schoenberg Mark | Chief Medical Officer | Sell (S) | 10K | $250K |
| Oct 8, 2025 | Degnan Chris | Chief Financial Officer | Sell (S) | 2K | $37K |
Connected entities for URGN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/URGN/capital-change-brief"
Use Arkolith's capital_change_brief for URGN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for URGN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.